Navigation Links
Veritas Genetics Breaks $1,000 Whole Genome Barrier

BOSTON, Sept. 29, 2015 /PRNewswire/ -- Veritas Genetics today announced that the company is making it possible for participants in the Personal Genome Project (PGP) to be among the first to get their whole genome sequenced and interpreted for less than a $1,000.

Led by Veritas Genetics Co-Founder Dr. George Church, Professor of Genetics at Harvard Medical School and Director of the Personal Genome Project, PGP is a long-term effort to sequence thousands of complete genomes to enable research into personal genomics and personalized medicine. PGP has more than 16,000 participants worldwide.

The "$1,000 Genome" has long been considered the tipping point when sequencing and interpreting the human genome becomes commonplace and begins to rapidly increase what is known and to dramatically impact healthcare. The catchphrase underscores how far science has come since the actual cost of the Human Genome Project, estimated at $2.7 billion spent over a decade.

Since then, others have touted the $1,000 genome, but never before has an organization been able to include interpretation, which is the key to applying genetic information into decisions about disease monitoring, prevention, nutrition, exercise, and more. "This is a true milestone worth celebrating, since it includes interpretation and genetic counseling," says Dr. Church.

Veritas Genetics' collaboration with PGP is a natural step. Three of the company founders have over 10 years of experience in processing and understanding whole genomes from their work with PGP. In addition to Dr. Church, Veritas Genetics' Chief Scientific Officer Preston Estep is PGP's Director of Sequencing, and Dr. Joseph Thakuria, the company's Chief Medical Officer, serves as PGP's Medical Director.

"Today's announcement is a watershed moment that will truly change the way we take care of ourselves and our families," says Mirza Cifric, Veritas Genetics' CEO and Founder. "While the cost of sequencing has dramatically declined, there is still a need for interpretation and information that is tangible and actionable to help individuals live better and longer lives. At Veritas, we are unlocking the potential of the $1,000 genome starting with early adopters, PGP participants. You can expect to see much more from us on this topic as we expand access beyond the PGP."

In June 2015, Veritas Genetics broke a similar barrier for breast and ovarian cancer by making its myBRCA genetic screening test of BRCA1 and BRCA2 available for $199. The myBRCA test showcases the range of genetic testing that Veritas Genetics will be offering, from specific panel tests through whole human genome sequencing. PGP participants are able to sign up with Veritas Genetics to have their whole genome sequenced at

About Veritas Genetics
Veritas Genetics is a global pioneer in disease prevention through accessible genetic information. By removing the barriers to genetic screening, Veritas empowers individuals and doctors to make informed lifestyle decisions that can lead to disease prevention and longer and healthier lives. Veritas is founded by leaders in genomics and operates globally from its offices in US, Europe and China.

Logo -

SOURCE Veritas Genetics
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Veritas Genetics Receives European CE Mark Approval for myBRCA Genetic Test for Hereditary Breast and Ovarian Cancer
2. Bureau Veritas Announces Sargam Laboratory Private Limited Name Change
3. Simplified Genetics Decodes DNAs Blueprint for Individual Health and Safety
4. Atossa Genetics en AAIPharma / Cambridge Major Laboratories kondigen productieovereenkomst aan voor Atossas belangrijkste kandidaat-geneesmiddel Afimoxifene Gel
5. Atossa Genetics and AAIPharma / Cambridge Major Laboratories Announce Manufacturing Agreement For Atossas Lead Drug Candidate Afimoxifene Gel
6. Quest Diagnostics and Myriad Genetics End BRCA Patent Litigation
7. New Stanford genetics course educates industry professionals
8. Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN
9. Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment
10. Axio Launches Statistical Genetics & Genomics Services
11. Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer
Post Your Comments:
(Date:12/9/2019)... ... December 09, 2019 , ... It’s a longstanding ... not ‘sebaceous,’” notes Dr. Robert Levine, a dual-board-certified dermatologist with Advanced Dermatology ... – cysts, which have their own distinct structure.” , “The common epidermoid cyst,” ...
(Date:12/8/2019)... NEW YORK (PRWEB) , ... December 08, 2019 , ... ... Obesity, and published in the journal Appetite, finds teens overwhelmingly engage with fast food, ... Thanksgiving and through Holidays is expected, especially when teens get stuck inside with family ...
(Date:12/6/2019)... ... December 06, 2019 , ... ... an expansion in services. While Kindred Nutrition and Wellness will continue to ... are now happy to offer Individual and Family Therapy and Yoga. , Kindred ...
Breaking Medicine Technology:
(Date:12/8/2019)... ... , ..., a trusted resource for online degree rankings ... 2020. The comprehensive research guide is based on an assessment of 104 accredited ... quality, graduation rate, reputation, and post-graduate employment. , The 2020 rankings are ...
(Date:12/6/2019)... , ... December 06, 2019 , ... ... used frequently, six students in Salt Lake Community College’s (SLCC) Emergency ... Mark Rodgers and Chelise Schaefer—were awarded the AT&T Public Safety Hero Scholarship to ...
(Date:12/6/2019)... ... December 06, 2019 , ... TIME For Kids (TFK) ... mix of educational, innovative, and fun destinations that are tailored to the interests of ... coolest places. , To assemble the list, TIME for Kids gathered nominations from its ...
(Date:12/5/2019)... ... December 05, 2019 , ..., a trusted ... 54 RHIT Degree Programs for 2020. The comprehensive research guide is based on ... is evaluated based on curriculum quality, graduation rate, reputation, and post-graduate employment. ...
(Date:12/4/2019)... ... ... WEDI , the nation’s leading nonprofit authority on the use of health ... the U.S. Department of Health and Human Services (HHS), announced today the winners of ... Conference in Arlington, Va. on Wednesday, December 4. , “The WEDI Board of Directors ...
Breaking Medicine News(10 mins):